#Flash: First Nasal Covid Vaccine gets DCGI Nod for Phase II
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
DCGI has given Bharat Biotech permission to undertake mid-to late-stage trials of their nasal Covid-19 vaccine. This is the first Covid-19 vaccine to go through human clinical trials in India. According to the ministry of science and technology, the Phase 1 trial in 18 to 60 years of healthy individuals age groups was well tolerated. Covaxin showed 77.8% effectiveness against symptomatic coronavirus and 65.2% protection against the B.1.617.2 Delta variant.

For more details please read here: https://www.thehindu.com/news/national/bharat-biotechs-nasal-covid-19-vaccine-gets-nod-for-phase-23-trial/article35898374.ece
P●●●●v P●●●r (●●●●●●●●) and 7 others like this5 shares
Like
Comment
Share